Loading…
Acrivon Therapeutics, Inc. is projected to decline to $1.45 by 2027, a -3% move from its current price of $1.50. ACRV is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/3/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $1.44 | $1.50 | $1.56 | -0.02% |
| Aug 6 | $1.42 | $1.50 | $1.58 | -0.05% |
| Aug 7 | $1.40 | $1.50 | $1.60 | -0.07% |
| Aug 8 | $1.39 | $1.50 | $1.62 | -0.09% |
| Aug 9 | $1.38 | $1.50 | $1.63 | -0.11% |
| Aug 10 | $1.37 | $1.50 | $1.64 | -0.14% |
| Aug 11 | $1.36 | $1.50 | $1.65 | -0.16% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.36 | $1.50 | $1.65 | -0.16% |
| Week 2 | $1.30 | $1.50 | $1.72 | -0.32% |
| Week 3 | $1.26 | $1.49 | $1.77 | -0.48% |
| Week 4 | $1.22 | $1.49 | $1.82 | -0.64% |
| Week 5 | $1.19 | $1.49 | $1.86 | -0.80% |
| Week 6 | $1.16 | $1.49 | $1.90 | -0.96% |
| Week 7 | $1.14 | $1.48 | $1.93 | -1.12% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Acrivon Therapeutics, Inc. is in Healthcare and operates as a clinical-stage biopharmaceutical company focused on oncology medicines. It discovers and develops therapies for patients whose tumors are predicted to be sensitive to each specific medicine by using its generative phosphoproteomics platform.
The company also runs Acrivon Predictive Precision Proteomics (AP3), a precision medicine platform that enables the creation of drug specific proprietary OncoSignature companion diagnostics to identify patients who will benefit from its drug candidates. Acrivon was incorporated in 2018 and is based in Watertown, Massachusetts.
Acrivon Therapeutics, Inc. trades in the Healthcare space with a current price of $1.43 and a market capitalization of $61.21M. It ranks 4439 by market capitalization within its universe. The stock shows a bearish near-term technical posture, yet the forecast data point to a path of gradual, long-run upside from the mid-2020s into the 2040s and beyond.
A major floor 34.2% below — a decisive break under it would weaken the trend.
The nearest floor, 4.7% below — buyers have tended to step in here.
The nearest ceiling, 42.0% above — a clean break opens room to run.
A major ceiling 59.1% above — clearing it would confirm fresh momentum.
Key ACRV support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ACRV market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.51 | Sell | $1.53 | Sell |
| MA 10 | $1.60 | Sell | $1.59 | Sell |
| MA 20 | $1.76 | Sell | $1.66 | Sell |
| MA 50 | $1.66 | Sell | $1.69 | Sell |
| MA 100 | $1.69 | Sell | $1.72 | Sell |
| MA 200 | $1.86 | Sell | $1.90 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 38.69 | Neutral |
| Stoch RSI (14) | 15.01 | Buy |
| CCI (20) | -106.15 | Sell |
| Williams %R (14) | -90.00 | Info |
| MACD (12,26,9) | -0.04 | Sell |
| ROC (12) | -21.87 | Sell |
| Bollinger %B (20,2) | 0.17 | Neutral |
| Stochastic %K (14) | 10.00 | Buy |
| TRIX (15) | -0.07 | Sell |
| Awesome (5,34) | -0.19 | Sell |
| Ultimate (7,14,28) | 28.40 | Buy |
| Momentum (10) | -0.25 | Sell |
| Aroon Osc (25) | -44.00 | Sell |
| Hull MA (9) | 1.45 | Buy |
| ADX (14) | 20.05 | Sell |
| ATR (14) | 0.06 | Info |
The near-term technical setup is bearish with an RSI of 30. The stock’s price is trading below both the 50-day and 200-day simple moving averages, which stand at $1.66 and $1.87 respectively. Current support sits at $1.43 and resistance at $2.13, creating a defined trading band.
Over the last 30 days, the price ranged from $1.12 to $1.83, and volatility remains elevated at 70% annualized.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.29 | $1.50 | $1.91 | 0% | Neutral | |
| $1.12 | $1.45 | $2.02 | -3% | Neutral | |
| $1.20 | $1.62 | $2.36 | +8% | Neutral | |
| $1.04 | $1.45 | $2.19 | -3% | Neutral | |
| $1.09 | $1.58 | $2.46 | +5% | Neutral | |
| $1.49 | $2.21 | $3.56 | +48% | Bullish | |
| $1.48 | $2.26 | $3.71 | +50% | Bullish | |
| $1.47 | $2.29 | $3.86 | +53% | Bullish | |
| $1.47 | $2.34 | $4.02 | +56% | Bullish | |
| $1.33 | $2.18 | $3.80 | +45% | Bullish | |
| $1.92 | $3.48 | $6.56 | +132% | Bullish | |
| $3.03 | $6.65 | $14.02 | +344% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $1.29 | $1.50 | $1.80 | +0.00% |
| September 2026 | $1.20 | $1.44 | $1.78 | -4.32% |
| October 2026 | $1.22 | $1.47 | $1.84 | +2.35% |
| November 2026 | $1.24 | $1.51 | $1.92 | +2.91% |
| December 2026 | $1.21 | $1.48 | $1.91 | -1.78% |
Click any year to see its month-by-month ACRV forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The ACRV price prediction for 2026 points to an average of $1.50 (low $1.29, high $1.91) — a potential gain of 0% on today's $1.50. A consolidation phase looks the most probable path here.
In 2027, ACRV is projected to trade between $1.12 and $2.02, averaging $1.45 — a potential decline of -3% from today's $1.50. That is -3% versus the projected 2026 average. Price action looks broadly range-bound.
Acrivon Therapeutics, Inc.'s 2028 outlook centres on $1.62, within a $1.20 to $2.36 range. That is up +11% on the projected 2027 average. That marks a +8% change versus current levels. A consolidation phase looks the most probable path here.
By 2029, ACRV could reach as high as $2.19, with a base case around $1.45 and support toward $1.04 — roughly -3% from $1.50. Price action looks broadly range-bound.
Expect ACRV to range from $1.09 to $2.46 through 2030. The $1.58 average target implies a +5% move from current prices. That is up +9% on the projected 2029 average. A consolidation phase looks the most probable path here.
The ACRV price prediction for 2031 points to an average of $2.21 (low $1.49, high $3.56) — a potential gain of +48% on today's $1.50. Momentum favours further upside here.
In 2032, ACRV is projected to trade between $1.48 and $3.71, averaging $2.26 — a potential gain of +50% from today's $1.50. That is up +2% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Acrivon Therapeutics, Inc.'s 2033 outlook centres on $2.29, within a $1.47 to $3.86 range. That is up +2% on the projected 2032 average. That marks a +53% change versus current levels. Momentum favours further upside here.
By 2034, ACRV could reach as high as $4.02, with a base case around $2.34 and support toward $1.47 — roughly +56% from $1.50. Buyers look set to stay in control over this stretch.
Expect ACRV to range from $1.33 to $3.80 through 2035. The $2.18 average target implies a +45% move from current prices. That is -7% versus the projected 2034 average. Momentum favours further upside here.
The ACRV price prediction for 2040 points to an average of $3.48 (low $1.92, high $6.56) — a potential gain of +132% on today's $1.50. Buyers look set to stay in control over this stretch.
In 2050, ACRV is projected to trade between $3.03 and $14.02, averaging $6.65 — a potential gain of +344% from today's $1.50. That is up +91% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in ACRV today (≈ 666.666667 ACRV) could be worth
$4,436.03
+$3,436.03 (+344%) by 2050 · US Dollar
Based on the average projected ACRV price of $6.65 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ACRVwould be worth at today's price.
$1,000 invested in ACRV on Jul 31, 2025 (≈ 781.250017 ACRV) would be worth
$1,171.88
+$171.88 (+17.2%) today · 1.17× · US Dollar
Based on a ACRV entry price of $1.28 vs. today's $1.5.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.6 | $937.5 | -6.3% |
| 1 month ago | $1.73 | $867.05 | -13.3% |
| 3 months ago | $2.09 | $717.7 | -28.2% |
| 6 months ago | $1.81 | $828.73 | -17.1% |
| 1 year ago | $1.28 | $1,171.88 | +17.2% |
| All time (3.7y) ago | $16.64 | $90.14 | -91.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ACRV forecast.
Our base-case forecast reaches $3.00 around 2040.
Implied market cap at $3.00: $128.41M
Forecasts project a modest start to the period with 2026 avg $1.43 and 2027 avg $1.38, then a clear upturn beginning in 2031 as the avg moves to $2.01, $2.04, $2.08 and $2.12 through 2034. The 2031–2034 windows carry bullish sentiment with strong upside potential (2031 ROIs: 40.4%, 2032: 42.5%, 2033: 45.6%, 2034: 47.9%). The path extends into 2040 with an avg of $3.07 and 114.8% ROI, and into 2050 with an avg of $5.73 and 300.6% ROI.
Yearly min/max values accompany these forecasts, including 2031 min $1.35 / max $3.22, 2032 min $1.34 / max $3.36, 2033 min $1.34 / max $3.50, 2034 min $1.33 / max $3.63, 2040 min $1.69 / max $5.80, and 2050 min $2.61 / max $12.08. These are estimates and not guarantees, reflecting a wide range of possible outcomes over time.
Tap a question to reveal the answer.
Avg $1.44 with min $0.9995 and max $2.25; ROI 0.8%; sentiment Neutral.
The 2026 forecast is Neutral with avg $1.43 and ROI 0, and the longer horizon shows bullish upside beginning in 2031, with 2031–2034 ROI 40.4% to 47.9% and 2040 ROI 114.8% and 2050 ROI 300.6%, indicating potential upside but with uncertainty.
Yes—the forecast max reaches $3.63 in 2034, with 2031–2034 avg prices around $2.01–$2.12 and significant upside in later years.
Current price is $1.43 and market cap is $61.21M.
Bearish sentiment with RSI 14 at 30; SMA50 at $1.66 and SMA200 at $1.87; support at $1.43 and resistance at $2.13; 30-day range from $1.12 to $1.83 and volatility at 70%.
Acrivon Therapeutics, Inc. Community Discussion
0Share your Acrivon Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.